Trending Topic

3D illustration of human brain on black background
23 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Joseph Samaha, Jim Dagher, Shayan Abdollah Zadegan

Huntington’s disease (HD) is a neurodegenerative disease inherited in an autosomal dominant manner. It is caused by an expansion of cytosine, adenine, guanine (CAG) repeats within the huntingtin (HTT) gene, which is located on chromosome 4. This pathological expansion of CAG repeats results in the production of a mutant huntingtin protein with an abnormally long polyglutamine […]

Neurostimulation & Patients UK Experience

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 15th 2015

Dr. Simon Thomson, MBBS, FRCA, FIPP, International Neuromodulation Society (INS) president from 2009 – June 2015 is a consultant in neuromodulation and pain management at Basildon and Thurrock University NHS Trust, as well as serving on the staff of Addenbrookes Hospital, Cambridge. He presented a talk about the National Institute for Health and Care Excellence (NICE) technology assessment for spinal cord stimulation in England and Wales. The assessment concluded that spinal cord stimulation for neuropathic pain is clinically effective at an achievable cost, making it mandatory for all health bodies to commission it appropriately due to its demonstrated cost-effectiveness.

Disclaimer: The International Neuromodulation Society (INS) provides videotaped talks by physicians and patients about neuromodulation therapy on its YouTube channel. INS produced videos of talks presented at a public event in 2015 that was jointly organized by the INS and the Canadian Neuromodulation Society. The information presented should not be used as a substitute for medical treatment and advice.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup